Reply: Optimal use of cholinergic drugs in Alzheimer's disease

Brain. 2018 Sep 1;141(9):e69. doi: 10.1093/brain/awy205.

Harald Hampel^{1

2

3

4}, Enrica Cavedo^{1

2

3

4}, Andrea Vergallo^{1

2

3

4}; Alzheimer Precision Medicine Initiative (APMI)

¹ AXA Research Fund and Sorbonne University Chair, Paris, France.
² Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Paris, France.
³ Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France.
⁴ Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.

No abstract available

Publication types